DOI:
10.1055/s-00000137
Krankenhaushygiene up2date
LinksClose Window
References
Maertens JA, Raad II, Marr KA. et al.
Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial.
Lancet 2016;
387: 760-769
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.